We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




DNA Detection Platform Enables Real-Time Molecular Detection

By LabMedica International staff writers
Posted on 25 Dec 2025

A next-gen DNA detection platform enables real-time molecular detection by detecting nucleic acids directly without enzymes or thermocyclers, thereby slashing costs, reducing complexity, and boosting reliability in diverse environments. More...

InvenireX Limited’s (Newcastle Upon Tyne, UK) R.O.S.A.L.I.N.D. (Real-time Optical System for Automated Lab Imaging and Nano- Diagnostics) is an advanced, automated live-scanning diagnostic instrument designed to deliver precise, high-throughput sample analysis in real time. Targeted at laboratories, research centers, and diagnostic facilities, R.O.S.A.L.I.N.D. combines sophisticated motion control with AI-powered analysis, enabling rapid, automated scanning of complex samples for highly accurate and reproducible results.

It enables rapid, precise, and amplification-free detection of nucleic acids by combining advanced DNA nanotechnology with smart automation. Each target molecule is isolated, trapped, and counted individually—providing absolute quantification down to attomolar levels for early, actionable insights. ‍The onboard neural net handles signal processing, protocol optimization, and decision support, delivering consistent, high-confidence results with minimal user input.

R.O.S.A.L.I.N.D automates intricate scanning tasks, traversing sample surfaces with precision and collecting detailed data points of single molecules, live digitally; greatly accelerating the workflow compared to manual methods. The instrument’s built-in AI continuously monitors data quality, dynamically adjusting focus, scan speed, and parameters to ensure optimal analysis conditions and immediately flagging potential points of interest or anomalies. R.O.S.A.L.I.N.D is compatible with multiple analytical protocols, making it adaptable across diverse fields.

Related Links:
InvenireX Limited


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: MG Tech adds STOMmics Stereo-seq spatial multi-omics technology to its potfolio (photo courtesy of STOmics)

MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.